Lineage Cell Therapeutics has acquired 1 company.
Lineage Cell Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
2173 Salk Avenue, Suite 200,
Carlsbad, California
92008
United States,
(442) 287-8990
www.lineagecell.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2019-03-11 |
Asterias Biotherapeutics, Inc. · Life Science
Fremont, California · www.asteriasbiotherapeutics.com Asterias Biotherapeutics, Inc. is a biotechnology company engages in the emerging field of regenerative medicine. The company’s proprietary cell therapy programs are based on its immunotherapy and pluripotent stem cell platform technologies. Asterias is presently focused on advancing three clinical-stage programs which have the potential to address areas of very high unmet medical need in the fields of oncology and neurology. Advisors: Dentons , Raymond James - Investment Banking |
- | Add-on Acquisition |
Lineage Cell Therapeutics
|
- |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
